Evidence map›Paper›PMID 32530919›Full record

ArticlePLoS genetics2020

Elevated exopolysaccharide levels in Pseudomonas aeruginosa flagellar mutants have implications for biofilm growth and chronic infections.

Joe J Harrison, Henrik Almblad, Yasuhiko Irie, Daniel J Wolter, Heather C Eggleston, Trevor E Randall, Jacob O Kitzman, Bethany Stackhouse, Julia C Emerson, Sharon Mcnamara and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 88 citations in OpenAlex.

  1. ImagingmBio · 2026
    Article
  2. Characterization ofJournal of bacteriology · 2026
    Article
  3. Journal of bacteriology · 2026
    Article
  4. Article
  5. Article
  6. bioRxiv : the preprint server for biology · 2025
    Article
  7. A biofilm-tropiceLife · 2025
    Article
  8. Article
  9. Flagellum-driven motility enhancesApplied and environmental microbiology · 2025
    Article
  10. Article
  11. Article
  12. Efficient Photolysis of Multidrug-Resistant Polymicrobial Biofilms.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  13. Article
  14. Flagellum-deficientMicrobiology spectrum · 2024
    Article
  15. Coacervate Dense Phase Displaces Surface-EstablishedJournal of the American Chemical Society · 2024
    Article
  16. The surface interface and swimming motility influence surface-sensing responses inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Joe J HarrisonDepartment of Biological Sciences, University of Calgary, University Drive NW, Calgary, AB, Canada.ORCID 0000-0003-0368-9539
Henrik AlmbladDepartment of Biological Sciences, University of Calgary, University Drive NW, Calgary, AB, Canada.ORCID 0000-0002-2010-3264
Yasuhiko IrieDepartment of Microbiology, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-7162-4772
Daniel J WolterDepartment of Microbiology, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0003-4321-8520
Heather C EgglestonDepartment of Microbial Infection and Immunity, Department of Microbiology, Center for Microbial Interface Biology, The Ohio State University, Columbus, Ohio, United States of America.ORCID 0000-0001-5217-4414
Trevor E RandallDepartment of Biological Sciences, University of Calgary, University Drive NW, Calgary, AB, Canada.ORCID 0000-0003-4402-9457
Jacob O KitzmanDepartment of Genome Sciences, University of Washington, Seattle, Washington, United States of America.
Bethany StackhouseDepartment of Genome Sciences, University of Washington, Seattle, Washington, United States of America.
Julia C EmersonCenter for Clinical and Translational Research, Seattle Children's Hospital, Seattle, Washington, United States of America.ORCID 0000-0003-1154-1665
Sharon McnamaraCenter for Clinical and Translational Research, Seattle Children's Hospital, Seattle, Washington, United States of America.ORCID 0000-0003-4895-3364
Tyler J LarsenDepartment of Microbiology, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-1566-4788
Jay ShendureDepartment of Genome Sciences, University of Washington, Seattle, Washington, United States of America.
Lucas R HoffmanDepartment of Microbiology, University of Washington, Seattle, Washington, United States of America.
Daniel J WozniakDepartment of Microbial Infection and Immunity, Department of Microbiology, Center for Microbial Interface Biology, The Ohio State University, Columbus, Ohio, United States of America.ORCID 0000-0003-4592-4816
Matthew R ParsekDepartment of Microbiology, University of Washington, Seattle, Washington, United States of America.
University of Washington · USUniversity of Calgary · CAInterface (United States) · USSeattle Children's Hospital · US

Funding

Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss, Lucas R Hoffman · 2010 to 2026
$21.4M
The pel exopolysaccharide gene cluster of Pseudomonas aeruginosaR01AI077628 · NIAID · UNIVERSITY OF WASHINGTON · PI MATTHEW R. PARSEK, Daniel J Wozniak · 2009 to 2026
$7.1M
The biofilm matrix of P. aeruginosaR01AI143916 · NIAID · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL, PARSEK, MATTHEW R. · 2019 to 2023
$2.9M
Revisiting alginate paradigmsR01AI134895 · NIAID · OHIO STATE UNIVERSITY · PI WOZNIAK, DANIEL J · 2018 to 2022
$2.5M
The matrix of Pseudomonas aeruginosa biofilmsR01AI061396 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI WOZNIAK, DANIEL J · 2005 to 2009
$2.1M
CIHRNIAID NIH HHS R01 AI061396NIAID NIH HHS R01 AI077628NIAID NIH HHS R01 AI134895NIAID NIH HHS R01 AI143916NIDDK NIH HHS P30 DK089507
6 · The paper itself

Abstract

Pseudomonas aeruginosa colonizes the airways of cystic fibrosis (CF) patients, causing infections that can last for decades. During the course of these infections, P. aeruginosa undergoes a number of genetic adaptations. One such adaptation is the loss of swimming motility functions. Another involves the formation of the rugose small colony variant (RSCV) phenotype, which is characterized by overproduction of the exopolysaccharides Pel and Psl. Here, we provide evidence that the two adaptations are linked. Using random transposon mutagenesis, we discovered that flagellar mutations are linked to the RSCV phenotype. We found that flagellar mutants overexpressed Pel and Psl in a surface-contact dependent manner. Genetic analyses revealed that flagellar mutants were selected for at high frequencies in biofilms, and that Pel and Psl expression provided the primary fitness benefit in this environment. Suppressor mutagenesis of flagellar RSCVs indicated that Psl overexpression required the mot genes, suggesting that the flagellum stator proteins function in a surface-dependent regulatory pathway for exopolysaccharide biosynthesis. Finally, we identified flagellar mutant RSCVs among CF isolates. The CF environment has long been known to select for flagellar mutants, with the classic interpretation being that the fitness benefit gained relates to an impairment of the host immune system to target a bacterium lacking a flagellum. Our new findings lead us to propose that exopolysaccharide production is a key gain-of-function phenotype that offers a new way to interpret the fitness benefits of these mutations.

Indexed as

Gene Expression Regulation, BacterialBacterial ProteinsBiofilmsBiosynthetic PathwaysCystic FibrosisFlagellaHost-Pathogen InteractionsHumansMutagenesis, Site-DirectedMutationPolysaccharides, BacterialPseudomonas aeruginosaPseudomonas InfectionsSelection, GeneticBacterial ProteinsPolysaccharides, Bacterial

Identifiers

PMID32530919
PMCPMC7314104
OpenAlexW3034732466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.